Safety and Tolerability of PQ912 in Subjects With Early Alzheimer's Disease

NCT02389413 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

120

Enrollment

INDUSTRY

Sponsor class

Conditions

Alzheimer's Disease

Interventions

DRUG: PQ912 oral
OTHER: Placebo

Sponsor

Vivoryon Therapeutics N.V.

Collaborators

[object Object]
[object Object]